Farid Saad (F Saad)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Benign Prostatic Hyperplasia

Radical Prostatectomy

Top Venues

The aging male : the official journal of the International Society for the Study of the Aging Male

Androgens: clinical research and therapeutics

Diabetes, obesity & metabolism

Vascular health and risk management

This page only lists publications with an associated author ORCID identifier.

Publications

Karim Sultan Haider, Michael Zitzmann, Pravinath Ramachandran, Carola S König, Geoffrey I Hackett, Ahmad Haider, Farid Saad, Pieter Desnerck, Richard C Strange, Amar Mann, Sudarshan Ramachandran
Testosterone therapy over 60 months improves aging male symptoms scores in all men with adult-onset testosterone deficiency. The aging male : the official journal of the International Society for the Study of the Aging Male 27 (1) (2024)
David K Twitchell, Michael B Christensen, Geoffrey Hackett, Abraham Morgentaler, Farid Saad, Alexander W Pastuszak
Examining Male Predominance of Severe COVID-19 Outcomes: A Systematic Review. Androgens: clinical research and therapeutics 3 (1) (2022)
Aksam Yassin, Farid Saad, Mustafa Alwani, Omar M Aboumarzouk, Raed M Al-Zoubi, Joanne Nettleship, Daniel Kelly, Abdulla A Al-Ansari
The effects of long-term testosterone treatment on endocrine parameters in hypogonadal men: 12-year data from a prospective controlled registry study. The aging male : the official journal of the International Society for the Study of the Aging Male 25 (1) (2022)
Abraham Morgentaler, Abdulmaged M Traish, Rajat S Barua, Paresh Dandona, Sandeep Dhindsa, Mohit Khera, Farid Saad
Recognizing the True Value of Testosterone Therapy in Health Care. Androgens: clinical research and therapeutics 3 (1) (2022)
Abraham Morgentaler, Abdulmaged M Traish, Rajat S Barua, Paresh Dandona, Sandeep Dhindsa, Mohit Khera, Farid Saad
Recognizing the True Value of Testosterone Therapy in Health Care. Androgens: clinical research and therapeutics 3 (1) (2022)
Mustafa Alwani, Aksam A Yassin, Raidh Talib, Ahmad R Al-Qudimat, Omar Aboumarzouk, Raed M Al-Zoubi, Farid Saad, Karim S Haider, Abdulla Al Ansari
Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data. Vascular health and risk management 17 (2021)
Aksam A Yassin, Mustafa Alwani, Riadh Talib, Yousef Almehmadi, Joanne E Nettleship, Khalid Alrumaihi, Bassam Albaba, Daniel M Kelly, Farid Saad
Long-term testosterone therapy improves liver parameters and steatosis in hypogonadal men: a prospective controlled registry study. The aging male : the official journal of the International Society for the Study of the Aging Male 23 (5) (2021)
Xiao Zhang, Hongwei Zhao, Jennifer Horney, Natalie Johnson, Farid Saad, Karim Sultan Haider, Ahmad Haider, Xiaohui Xu
Recent testosterone drop-off and risk of cardiovascular events. The aging male : the official journal of the International Society for the Study of the Aging Male 23 (5) (2021)
Paresh Dandona, Sandeep Dhindsa, Husam Ghanim, Farid Saad
Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review. Diabetes, obesity & metabolism 23 (1) (2020)
Farid Saad, G Doros, K S Haider, A Haider
Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from a controlled registry study. International journal of obesity (2005) 44 (6) (2020)
Karim Sultan Haider, Ahmad Haider, Farid Saad, Gheorghe Doros, Markolf Hanefeld, Sandeep Dhindsa, Paresh Dandona, Abdulmaged Traish
Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study. Diabetes, obesity & metabolism 22 (11) (2020)
Donald Pfaff, Farid Saad
Sexual motivation: problem solved and new problems introduced. Hormone molecular biology and clinical investigation 41 (2) (2020)
Farid Saad, Monica Caliber, Gheorghe Doros, Karim Sultan Haider, Ahmad Haider
Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality. The aging male : the official journal of the International Society for the Study of the Aging Male 23 (1) (2019)
Xiao Zhang, Yan Zhong, Farid Saad, Karim Sultan Haider, Ahmad Haider, Angela G Clendenin, Xiaohui Xu
Testosterone therapy may reduce prostate cancer risk due to testosterone deficiency at a young age via stabilizing serum testosterone levels. The aging male : the official journal of the International Society for the Study of the Aging Male 23 (2) (2019)
Ahmad Haider, Karim Haider, Farid Saad, Markolf Hanefeld
Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for "late-onset" hypogonadism: A case report. SAGE open medical case reports 7 (2019)
Aksam Yassin, Ahmad Haider, Karim S Haider, Monica Caliber, Gheorghe Doros, Farid Saad, W Timothy Garvey
Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study. Diabetes care 42 (6) (2019)
Farid Saad, Gheorghe Doros, Karim Sultan Haider, Ahmad Haider
Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms. Investigative and clinical urology 59 (6) (2018)